Company overview

ContextVision is a medical technology software company that specializes in image analysis and artificial intelligence. ContextVision is the global market leader within image enhancement and is a software partner to leading medical imaging manufacturers all over the world. Its cutting-edge technology helps doctors accurately interpret medical images, a crucial foundation for better diagnosis and treatment.

ContextVision is a global market leader within image enhancement and a software partner to the world’s most recognized medical imaging manufacturers.

The present multimodality product portfolio covers 2D/3D/4D Ultrasound, MRI, X-Ray and Mammography.
As an industry pioneer for more than 30 years, ContextVision is taking a leading position within deep learning, the latest artificial intelligence technology, to broaden its product portfolio and enter a new rapidly growing market – digital pathology. 
As an industry pioneer for more than 30 years, ContextVision is significantly investing in R&D to develop new applications of the latest artificial intelligence technologies and expanding into the growing digital pathology market. The release of its first product, supporting the diagnosis of prostate cancer, is planned in the near future.
ContextVision is based in Sweden, with local presentation in the U.S., Russia, Japan, China and Korea.
ContextVision is listed on the Oslo Stock Exchange under the ticker COV.

Company presentation

Investors contact

For investors information and/or inquiries, please contact
Anita Tollstadius, CEO